US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 70.540
  • -2.590-3.54%
Close Jan 10 16:00 ET
  • 70.990
  • +0.450+0.64%
Pre 08:27 ET
13.59BMarket Cap783.78P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Incyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.011B--
--2024/Q4-- / 1.144B--
Oct 29, 20242024/Q31.138B / 1.077B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.011B--
--2024/Q4-- / 1.144B--
Oct 29, 20242024/Q31.138B / 1.077B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--

Unlock Free Earnings Estimates

Incyte Earnings Reports

  • Incyte | 10-Q: Q3 2024 Earnings Report

    Oct 29, 2024 16:05 ET

  • Incyte | 8-K: Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

    Oct 29, 2024 07:08 ET

  • Incyte | 10-Q: Q2 2024 Earnings Report

    Jul 30, 2024 16:18 ET

  • Incyte | 8-K: Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

    Jul 30, 2024 07:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 13, 2025

    Buy

    • Buy

      42.86%

    • Hold

      50.00%

    • Sell

      7.14%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme CAR-T Therapy
    CAR-T Therapy
    Intraday-0.54%